autologous NK cell therapy (Takara Bio/Kyoto Prefectural University of Medicine)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous NK cell therapy (Takara Bio/Kyoto Prefectural University of Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsStomach NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakara Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyoto Prefectural UniversityTakara Bio Inc
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A